Vaporized Viral Vector Shows Promise In Anti-Cancer Gene Therapy
A new lung cancer therapy employing a vaporized viral vector to deliver a cancer-inhibiting molecule directly to lung tissue shows early promise in mouse trials, according to researchers at the Ministry of Education, Science and Technology in Korea. Gene therapy is an area of great promise, but delivery mechanisms, which have included intravenous injection and intratracheal instillation, have proven problematic for effective delivery of genetic therapy to lung tissues.
read more
print page
Deceases & treatment
- Specific immunotherapy (xenovaccinotherapy) for cancer
- T-cell vaccination (autovaccinotherapy) for autoimmune diseases
- Regenarative therapy
- Clinical application of stem celltransplantation
- Cell transplantation (CT) in treating severe neurological disorders (general information)
- Hepatic diseases
- Osteomielitis
- Arthrosis
